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The Signal-Dependent Coactivator CBP
Is a Nuclear Target for pp90RSK
Toshihiro Nakajima,†§ Akiyoshi Fukamizu,† al., 1994). By contrast, the KID region appears to induce
target gene expression by binding to the coactivatorJun Takahashi,‡ Fred H. Gage,‡ Tracy Fisher,*
John Blenis,* and Marc R. Montminy†§ CREB-binding protein (CBP) and its paralog P300 in
a phospho-Ser-133-dependent manner (Chrivia et al.,*Department of Cellular and Molecular Physiology
Harvard Medical School 1993; Eckner et al., 1994; Parker et al., 1996). Following
Ser-133 phosphorylation, CREB binds to a discrete 80Boston, Massachusetts 02115
†The Peptide Biology Laboratories amino acid KID interaction domain in CBP (amino acids
591–670) termed KIX. The functional importance of theThe Foundation for Medical Research
‡Laboratory of Genetics CREB–CBP complex for transcriptional induction by
cAMP has been demonstrated by immuno-neutraliza-The Salk Institute
La Jolla, California 92037 tion experiments with CBP antiserum and by transfec-
tion assays in which overexpression of a CBP effector
plasmid potentiated CREB activity in a phospho-Ser-
133-dependent manner (Arias et al., 1994; Kwok et al.,Summary
1994). In cellular microinjection experiments, moreover,
purified KIX polypeptide could also block transcriptionalWe have examined the mechanism by which growth
induction of a cAMP-responsive reporter by interferingfactor–mediated induction of the Ras pathway inter-
with recruitment of phospho-CREB to endogenous CBPferes with signaling via the second messenger cAMP.
(Parker et al., 1996).Activation of cellular Ras with insulin or NGF stimu-
In addition to mediating transcription of cAMP-latedrecruitment of theS6 kinase pp90RSK to the signal-
responsive genes, CBP also appears to function as adependent coactivator CBP. Formation of the pp90RSK–
coactivator for mitogen-inducible transcription factors.CBP complex occurred with high stoichiometry and
In cellular microinjection experiments, for example, CBPpersisted for 6–8 hr following growth factor addition.
antiserum was found to block transcriptional inductionpp90RSK specifically recognized the E1A-binding do-
of phorbol ester– and serum-responsive reporter genesmain of the coactivator CBP. In addition, like E1A,
(Arias et al., 1994). The ability of CBP to mediate re-binding of pp90RSK to CBP was sufficient to repress
sponses to cAMP as well as to mitogenic signals hastranscriptionof cAMP-responsivegenes via the cAMP-
prompted us to propose that these pathways may an-inducible factor CREB. By contrast with its effects
tagonize each other by virtue of their convergence on aon the cAMP pathway, formation of the pp90RSK–CBP
common coactivator. In this regard, a number of growthcomplex was required for induction of Ras-responsive
factors, among them insulin and nerve growth factorgenes. These results provide a demonstration of
(NGF), appear to stimulate gene expression via a Ras-cross-coupling between two signaling pathways that
dependent mechanism (Ginty et al., 1994; Jhun et al.,occurs at the level of a signal-dependent coactivator.
1994; Medema et al., 1991; Stumpo et al., 1988; Visvader
et al., 1988). Insulin has also been shown to repressIntroduction
transcription of cAMP-responsive genes such as phos-
phoenolpyruvate carboxykinase (PEPCK), in part by in-A number of signaling pathways stimulate gene expres-
terfering with CREB-mediated transactivation (Quinn,sion via the phosphorylation of specific nuclear factors
1994). The opposing effects of insulin on Ras- and(Hunter and Karin, 1992). The second messenger cyclic
cAMP-mediated transcription have led us to examineAMP (cAMP), for example, has been shown to induce
the mechanisms underlying transcriptional interferencetranscription of target genes by the protein kinase A
between these signaling pathways.(PKA)-dependent phosphorylation of cAMP response
Here we show that growth factor–dependent activa-element–binding protein (CREB) at Ser-133 (Gonzalez
tion of the Ras pathway represses CREB activity byand Montminy, 1989). Although phosphorylation may
inducing recruitment of pp90RSK to CBP. pp90RSK binds toregulate nuclear factors by modulating their nuclear tar-
a region of CBP that is also recognizedby the adenovirusgeting or DNA binding properties, CREB belongs to a
oncoprotein E1A (Eckner et al., 1994). In addition, likegroup of signal-dependent activators whose transacti-
E1A, pp90RSK represses transcription of cAMP-respon-vation potential is specifically affected.
sive genes upon binding to CBP. Since overexpressionThe CREB transactivation domain is bipartite, con-
of the pp90RSK-binding domain of CBP can reverse thesisting of inducible and constitutive activators, termed
inhibitory effects of the Ras pathway onCREB-mediatedKID and Q2, respectively, that function synergistically
transcription, these results provide evidence for cross-in response to PKA stimulation (Brindle et al., 1993;
coupling between two pathways that occurs at the levelQuinn, 1993). Q2 has been shown to activate transcrip-
of a signal-dependent coactivator.tion by interacting constitutively with dTAF110, a com-
ponent of the basal transcription factor TFIID (Ferreri et
Insulin Represses CREB Activity via a
Ras-Dependent Mechanism§Present address: Research Division, Joslin Diabetes Center, De-
Insulin has been shown to inhibit expression of thepartment of Cellular and Molecular Physiology, Harvard Medical
School, Boston, Massachusetts 02215. cAMP-responsive PEPCK gene by interfering with the
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Figure 1. Insulin Inhibits CREB Activity via a Ras-Dependent Mechanism
(a) Representative CAT assay of H4IIE hepatoma cells using a cAMP-inducible 2134 PEPCK-CAT reporter construct that contains a consensus
cAMP-responsive element from 296 to 286. Where indicated, cells were treated with forskolin (F, gray bars), insulin (I, dotted bars), insulin
plus forskolin (I1F, closed bars), or ethanol vehicle (C, striped bars). H4IIE cells were also cotransfected with increasing amounts of dominant-
negative N17 Ras expression plasmid, as indicated below each set of bars. Percent conversion, percent [14C]chloramphenicol converted to
acetylated forms.
(b) H4IIE cells transfected with wild-type (GAL CREB) or phosphorylation-defective (S/A 133) GAL4–CREB expression vectors containing the
CREB transactivation domain (amino acids 1–283) fused to the GAL4 DNA-binding domain. PKA activity was increased by cotransfection of
a PKA catalytic subunit expression vector. GAL CREB activity was monitored by cotransfected G5B-CAT reporter plasmid containing five
GAL4 recognition sites. P300, cells cotransfected with increasing amounts of CMV-P300 expression vector (2.5, 5, or 10 mg), as indicated by
crescendo bar. Bars indicate percent [14C]chloramphenicol converted to acetylated forms in each assay.
(c)Western blot assay of phospho-Ser-133 CREB and total CREBlevels in H4IIE cells using phospho-Ser-133-specific (5322) andnondiscriminat-
ing (244) CREB antisera. Cells were treated with forskolin (Forsk, 10 mM) or insulin (10 nM) or both for 30 min as indicated below each lane.
Arrow points to phospho-Ser-133 CREB immunoreactive band.
(d)Representative CAT assay of PC12 cells transfected with somatostatin CRE-CAT reporter plasmid (Gonzalez and Montminy, 1989). Dominant-
negative N17 Ras or dominant-active V61 Ras expression plasmids (1, 2, or 5 mg) were cotransfected with CRE-CAT reporter into PC12 cells
as indicated below each bar. Control and forskolin-treated cells are indicated by striped or open bars, respectively. GAL CREB, PC12 cells
transfected with GAL4–CREB expression plasmid plus G5B-CAT reporter vector. Cells were cotransfected with dominant-negative N17 Ras
or dominant-active V61 Ras expression plasmids as indicated below each bar. Closed and striped bars correspond to cells transfected with
wild-type (PK-A wt) or catalytically inactive PKA (PK-A mut), respectively. Bars indicate percent [14C]chloramphenicol converted to acetylated
forms in each assay.
transcriptional activity of CREB in hepatic cells (Quinn, this kinase cascade.Overexpression of a dominant-neg-
ative N17 Ras expression plasmid in H4IIE cells blocked1994; Sasaki et al., 1984). To examine the mechanism
underlying this repression, we initiated a series of tran- the inhibitory effects of insulin on PEPCK promoter ac-
tivity in a dose-dependent manner (Figure 1a), sug-sient transfection assays in H4IIE hepatoma cells. Fol-
lowing treatment with 10 mM forskolin, PEPCK promoter gesting that the inhibition of PEPCK expression is in-
deed Ras mediated.activity was induced 12-fold in H4IIE cells, and cotreat-
ment with insulin (10 nM) severely attenuated this re- Insulin similarly inhibited the PKA-dependent induc-
tion of a GAL4–CREB expression vector containing thesponse (Figure 1a). The ability of insulin to stimulate
gene expression via a Ras-dependent mechanism (Jhun CREB transactivation domain (amino acids 1–283) fused
to the GAL4 DNA-binding domain (amino acids 1–147)et al., 1994; Medema et al., 1991) prompted us to exam-
ine whether insulin might also inhibit CREB activity via (Figure 1b). However, insulin treatment did not alter the
Multiple Pathways Converge on the Coactivator CBP
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Figure 2. A 90 kDa Mitogen-Activated Ser/
Thr Kinase Associates with CBP and Inhib-
its cAMP-Dependent Transcription Following
Ras Activation
(a) Immune complex kinase assays of immu-
noprecipitates from PC12 GSRasDN1 cells
prepared with CBP antiserum 5614. Extracts
were prepared from serum-treated or quies-
cent cells as indicated below each lane. The
presence of SDS(0.5%) in the immunoprecip-
itation reaction is indicated. Relative mass (in
kilodaltons) is shown alongside. 32P-labeled
270 kDa band corresponds to CBP.
(b) In-gel kinase assay of CBPimmunoprecip-
itates prepared from PC12 GSRasDN1 cells.
Immunoprecipitates were collected from qui-
escent (minus) or serum-stimulated (plus)
cells as indicated below each lane. Dexa-
methasone (DEX) treatment was used to in-
duce dominant-negative N17 Ras expression
in PC12 GSRasDN1 cells as labeled. Relative
mass (in kilodaltons) indicated on left.
(c) Phosphoamino acid analysis of the auto-
phosphorylated 90 kDa kinase identified by
in-gel kinase assay in (b). Relative migration
of phospho-serine (S) phospho-threonine (T),
and phospho-tyrosine (Y) is shown.
(d) Time course of complex formation be-
tween CBP and the 90 kDa Ser/Thr kinase. In-
gel kinase assay of CBP immunoprecipitates
prepared from Jurkat T cells following serum
stimulation. Time (in hours) following induc-
tion is shown above each lane. Comparable
results were obtained in PC12 and H4IIE
cells.
phosphorylation of CREB at Ser-133 (Figure 1c), sup- shown). Induction of N17 Ras did not enhance Ser-133
phosphorylation of CREB, however, suggesting that theporting the notion that insulin acts downstream of PKA
to inhibit CREB activity. In this regard, cotransfection Ras pathway acts downstream of phospho-Ser-133
CREB to modulate cAMP-dependent transcription (dataof an expression vector for P300 (Figure 1b) or CBP (data
not shown) suppressed the inhibitory effect of insulin not shown).
on GAL4–CREB activity, restoring PKA inducibility in
a phospho-Ser-133-dependent manner. P300 had no pp90RSK Associates with CBP and Inhibits CREB
Activity in Response to Ras Activationeffect on the transcriptional activity of a phosphoryla-
tion-defective GAL4–CREB (Ser/Ala-133) effector plas- The Ras pathway has been shown to regulate a number
of nuclear activators via a cascade of kinases that phos-mid, however (Figure 1b). These results suggest that
insulin inhibits induction of cAMP-responsive genes by phorylate these factors in response tomitogenic signals.
Remarkably, immunoprecipitates of CBP prepared fromspecifically interfering with CBP activity.
To determine whether the Ras-dependent inhibition serum-treated but not quiescent PC12 cells were found
to contain a kinase activity that could phosphorylateof CREB was limited to hepatocytes, we performed tran-
sient transfectionassays inheterologouscell lines. When CBP in vitro (Figure 2a). In-gel kinase analysis of these
CBP immunoprecipitates revealed the presence of a 90transfected into PC12 cells (Figure 1d), a dominant-
active (Val-61) Ras expression plasmid repressed kDa auto-phosphorylated kinase in samples from serum
treated by nonquiescent cells (Figure 2b). The 90 kDacAMP-regulated enhancer–chloramphenicol acetyl-
transferase (CRE-CAT) reporter activity in a dose-de- kinase contained phospho-serine by phosphoamino
acid analysis (Figure 2c). Dexamethasone-induced ex-pendent manner, whereas a dominant-negative (Asn-
17) Ras expression plasmid actually potentiated CRE- pression of dominant-negative N17 Ras blocked the for-
mation of the CBP–kinase complex in PC12 GSRasDN1CAT reporter activity in response to forskolin treatment.
Dominant-negative Ras similarly potentiated the activity cells (Figure 2b) but not in parental PC12 cells (data not
shown), indicating that the 90 kDa CBP Ser/Thr kinaseof a GAL4–CREB expression vector in response to PKA,
whereas dominant-active (Val-61) Ras strongly inhibited was regulated via a Ras-dependent mechanism. Forma-
tion of the CBP–kinase complex was detected in a num-GAL4–CREB-dependent induction (Figure 1d). In PC12
GSRasDN1cells, which expressdominant-negative N17 ber of cell lines, including H4IIE and Jurkat T cells. In
Jurkat cells, as well as in other cell types, CBP–kinaseRasunder controlof the glucocorticoid-inducible mouse
mammary tumor virus promoter (Thomas et al., 1992), complex formation peaked 60 min after Ras induction
and persisted for 6 hr (Figure 2d).induction of dominant-negative N17 Ras by dexametha-
sone treatment also potentiated CREB activity (data not Based on its preference for peptide substrates with
Cell
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Figure 3. pp90RSK Associates with the E1A-
Binding Region of CBP/P300 and Inhibits
CREB Activity in Response to Ras Activation
(a) In-gel kinase and Western blot (a-RSK)
analysis of immunoprecipitates prepared
from serum-treated PC12 GSRasDN1 cells
with preimmune rabbit serum (PI) or rabbit
polyclonal antisera against the CREB-binding
domain of CBP (5614, amino acids 455–679).
Western blot analysis was performed with
anti-pp90RSK antiserum on immunoprecipi-
tates of CBP (5614). Arrow points to pp90RSK.
(b) In-gel kinase assay of pp90RSK activity fol-
lowing pull-down assay with GST–CBP fusion
proteins. Inclusive amino acid endpoints for
each CBP construct are shown above each
lane. GST, control pull-down assay per-
formed with GST alone. 5614, pp90RSK activity
obtained following immunoprecipitation of
PC12 GSRasDN1 nuclear extracts with CBP
antiserum 5614. Arrow points to pp90RSK. Mo-
lecular mass, in kilodaltons, is shown on the
left. Additional band above 90 kDa corre-
sponds to hyperphosphorylated form of
pp90RSK.
(c) CAT assay of PC12 GSRasDN1 cells using
GAL4–CREB expression vector and G5B-
CAT reporter plasmid. Cells were cotrans-
fected with wild-type (RSK) or catalytically
inactive (RSK N9C9) avian pMT2 pp90RSK ex-
pression plasmids and compared against control (CON) metallothionine expression vector (pMT2 Ca9 encoding catalytically inactive catalytic
subunit of PKA). Effect of control pMT2 Ca2 plasmid on reporter activity was identical to pMT2 backbone vector alone. Closed bars, cells
treated with forskolin (10 mM); striped bars, cells treated with control dimethyl sulfoxide (DMSO) vehicle as indicated. Assays were performed
in triplicate with standard error as indicated. Bars indicate percent chloramphenicol converted to acetylated forms. All assays were normalized
to bGal activity derived from internal RSV-bGal control plasmid.
(d) Binding of pp90RSK to P300 does not interfere with binding of phospho-CREB to P300. Autoradiogram of recombinant 32P-labeled phospho-
Ser-133 CREB following incubation with control (minus) or HA-P300-containing (plus) Sepharose resins. Prior to phospho-CREB binding assay,
in vitro translated HA epitope–tagged P300 protein was incubated with Sepharose resins containing GST only, GST–RSK, or anti-HA (aHA)
antiserum. Onput, 10% of total 32P-labeled phospho-CREB incubated with each Sepharose resin. Relative mass, in kilodaltons, is indicated
on the left.
RRXS consensus phosphorylation sites such as CREB transient transfection assays of PC12 cells, a wild-type
pp90RSK expression plasmid had no effect on GAL4–and the Kemptide fragment of pyruvate kinase in im-
mune complex kinase assays (data not shown), we spec- CREB activity in unstimulated cells, but inhibited PKA-
dependent activity about 5-fold (Figure 3c). To deter-ulated that the 90 kDa CBP-associated kinase may cor-
respond to the mitogen-activated pp90RSK (Chen et al., mine whether pp90RSK catalytic activity was critical for
this inhibition, we employed a catalytically inactive mu-1992). Immunoprecipitates of CBP, prepared from se-
rum-treated PC12 cells, were found to contain pp90RSK tant pp90RSK expression vector (RSK N9C9), containing
point mutations in both ATP-binding domains. Surpris-by Western blot assay (Figure 3a, lane 4). Moreover,
the immunoreactive pp90RSK protein coincided with the ingly, RSK N9C9 repressed PKA-dependent GAL4–CREB
activity to the same extent as wild-type pp90RSK (Figureauto-phosphorylated kinase we detected by in-gel ki-
nase assay (Figure 3a, lane 2). 3c), indicating that the association of pp90RSK with CBP
may be sufficient to inhibit transcription of cAMP-To identify the region of CBP that interacts with
pp90RSK, we performed affinity selection assays on a responsive genes.
Although affinity selection experiments revealed thatseries of glutathione S-transferase (GST)–CBP fusion
polypeptides. Only one region of CBP, extending from the pp90RSK-binding region of CBP (amino acids 1805–
1891) is distinct from the phospho-CREB-binding do-residues 1805–1891and corresponding to theE1A-bind-
ing domain of both CBP and P300 (Eckner et al., 1994), main (amino acids 591–670), we examined whether
pp90RSK may inhibit transcription of cAMP-responsiveexhibited cellular pp90RSK-binding activity by in-gel ki-
nase (Figure 3b) and Western blot assays (data not genes by blocking complex formation between CBP/
P300 and phospho-CREB. Toward this end, the phos-shown). pp90RSK also associated with full-length P300,
but not with mutant P300 protein (D33) lacking the E1A- pho-CREB-binding activity of HA epitope–tagged P300
protein was evaluated following affinity chromatographybinding domain (data not shown).
The ability of E1A to inhibit CREB activity by binding over anti-HA antibody orGST–pp90RSK Sepharose resins.
P300 protein that had been immobilized on GST–pp90RSKto CBP led us to examine whether activation of the
Ras pathway may similarly repress expression of cAMP- resin was found to associate with phospho-Ser-133
CREB at levels comparable with anti-HA-immobi-responsive genes via recruitment of pp90RSK to CBP. In
Multiple Pathways Converge on the Coactivator CBP
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Figure 4. Insulin Inhibits CREB Activity in He-
patic Cells by Stimulating the Association of
CBP with pp90RSK
(a) Western blot assay of CBP in total nuclear
extracts (ONPUT) or following immunopre-
cipitation with preimmune (PI), anti-pp90RSK
(aRSK), or anti-CBP (aCBP) antisera. Sam-
ples from quiescent (minus) or insulin-stimu-
lated (plus) H4IIE cells were as indicated.
Relative mass, in kilodaltons, is indicated
alongside. Arrow points to immunoreactive
CBP band.
(b) Representative two-hybrid transient trans-
fection assay of H4 RBD cells that express
the GAL4–pp90RSK binding domain (pp90RSK-
binding domain, amino acids 1805–1891 of
CBP [GAL4–RBD]) transgene versus H4IIE
cells expressing the GAL4 DNA-binding do-
main (amino acids 1–147) only. GAL4–RBD-
and GAL4-expressing cells were cotrans-
fected with G5B-CAT reporter plasmid plus
control CBP1-VP16 expression vector, which
encodes amino acids 1–100 of CBP fused
to the VP16 activation domain, or RSK-VP16
expression vector, which contains the cata-
lytically inactive pp90RSK cDNA (RSKN9C9; see
Figure 3e) fused to the VP16 activation do-
main. Open bars, control cells; closed bars,
cells treated with insulin; striped bars, cells
treated with insulinand transfectedwith dom-
inant-negative N17 Ras expression plasmid.
(c) Overexpression of the RBD of CBP
(CBP1680–1891) suppresses insulin-mediated in-
hibition of CREB activity. Representative CAT assay of control and insulin-treated H4IIE hepatoma cells following transfection with either wild-
type (GAL CREB) or phosphorylation-defective (S/A 133) GAL4–CREB effector plasmids (5 mg) plus G5B-CAT reporter vector (5 mg). CAT
activity is shown as percent [14C]chloramphenicol converted to acetylated forms. The presence of PKA (2.5 mg) and/or CBP1680–1891 (RBD)
expression plasmid (1, 2.5, or 5 mg) was as indicated.
(d) Overexpression of the RBD of CBP suppresses insulin-dependent inhibition of the endogenous PEPCK gene in H4 RBD cells. Northern
blot of total RNA from parental (P) H4IIE and stably transfected (S) H4 RBD cells that express the GAL4–RBD transgene (see [b]). RNAs were
harvested from quiescent (CON), forskolin-treated (FSK), or forskolin plus insulin–treated (INS1FSK) cells as indicated. Immobilized RNAs
were hybridized with 32P-labeled PEPCK or control tubulin cDNA probes as indicated. Relative position of 18S and 28S ribosomal RNAs is
shown.
lized P300 (Figure 3d). These results demonstrate that To test whether insulin stimulates pp90RSK–CBP com-
plex formation via a Ras-dependent mechanism, webinding of pp90RSK to P300/CBP per se does not interfere
with binding of phospho-Ser-133 CREB to P300/CBP. performed mammalian two-hybrid assays in a stably
transfected H4IIE cell line, termed H4 RBD, which ex-
presses a GAL4–CBP1805–1891 transgene encoding theInsulin Inhibits CREB Activity by Inducing
pp90RSK–CBP Complex Formation pp90RSK-binding domain (RBD) fused to the GAL4 DNA-
binding domain (Figure 4b). Although the expressedThe ability of pp90RSK to repress CREB activity in PC12
cells prompted us to examine whether insulin, which GAL4–CBP1805–1891 protein, referred toas GAL4–RBD, was
unable to stimulate a G5B-CAT reporter containing fivehas been shown to stimulate pp90RSK activation (Sturgill
et al., 1988), might also induce pp90RSK–CBP complex GAL4 recognition sites by itself, cotransfection of a
pp90RSK VP16 expression plasmid, containing the cata-formation in H4IIE hepatoma cells. Insulin treatment had
no effect on total CBP levels relative to unstimulated lytically inactive pp90RSK cDNA fused to the activation
domain of VP16, induced G5B-CAT reporter activitycells by Western blot assay (Figure 4a, compare lanes
1 and 2). However, immunoprecipitates of pp90RSK pre- 8- to 10-fold in response to insulin (Figure 4b). Cotrans-
fection of a N17 Ras expression plasmidblocked insulin-pared from insulin-treated cells were found to contain
high levels of CBP, whereas control cells did not (Figure dependent induction of the G5B-CAT reporter, demon-
strating that insulin stimulates the interaction of pp90RSK4a, lanes 4 and 5), indicating that insulin stimulates
pp90RSK–CBP complex formation in vivo. Remarkably, and CBP via a Ras-dependent mechanism (Figure 4b).
the amount of CBP recovered from pp90RSK immunopre-
cipitates of insulin-treated cells was comparable with Overexpression of the RBD of CBP Suppresses
Ras-Dependent Inhibition oftheamount obtainedfollowing immunoprecipitation with
anti-CBP antibody, demonstrating that a significant Phospho-CREB Activity
To test whether overexpression of the RBD of CBP canfraction of CBP associates with pp90RSK in response to
insulin (Figure 4a, compare lanes 5 and 6). suppress insulin-dependent inhibition of CREB activity
Cell
470
Figure 5. NGF Stimulates pp90RSK–CBPCom-
plex Formation in Wild-Type Cells but Not in
RBD-PC12 Cells, Which Express the RBD
of CBP
(Top) Western blot analysis of CBP immuno-
precipitates from wild-type (left) and RBD-
PC12 (right) cells using anti-CBP anti-
serum. Arrow points to 270 kDa CBP band.
Time after stimulation with NGF is indicated
over each lane.
(Middle) In-gel kinase assay of CBP immuno-
precipitates from wild-type and RBD-PC12
cells after stimulation with NGF. Arrow points
to pp90RSK activities. Multiple bands corre-
spond to hypo- and hyperphosphorylated
forms of pp90RSK.
(Bottom) Western blot analysis of immuno-
precipitates prepared with pp90RSK antiserum
after treatment with NGF. Western blot assay
was performed with anti-CBP antiserum
5614. Arrow points to coprecipitated CBP.
by interfering with complex formation between endoge- this complex in PC12 cells. In reciprocal coimmunopre-
cipitation studies with anti-CBP and anti-pp90RSK anti-nous CBP and pp90RSK, we performed transient transfec-
tion assays in H4IIE cells using an RBD expression plas- sera, pp90RSK–CBP complex formation was induced
within 15 min of NGF addition, peaked after 1 hr, andmid (Figure 4c). Cotransfection of the RBD expression
plasmid reversed the inhibitory effect of insulin on wild- persisted for 6 hr after stimulation (Figure 5, left). By
contrast, NGF did not stimulate pp90RSK–CBP complextype but not phosphorylation-defective (Ser-133/Ala-
133) GAL4–CREB activity in a dose-dependent manner. formation in RBD-PC12 cells that stably express the
GAL4–RBD transgene (Figure 5, right). NGF-dependentThe ability of the RBD to suppress insulin-dependent
inhibition of CREB activity prompted us to examine activation of mitogen-activated protein kinase (MAPK) in
RBD-PC12 cells, evaluated by immune complex kinasewhether expression of the GAL4–RBD transgene in H4
RBD cells correspondingly suppresses insulin-depen- assays with myelin basic protein as substrate, was com-
parable with that in wild-type PC12 cells (data notdent inhibition of the endogenous PEPCK gene. For-
skolin strongly induced PEPCK mRNA accumulation in shown), indicating that expression of the GAL4–RBD
transgene does not block pp90RSK–CBP interaction byboth parental H4IIE and stably transfected H4 RBD cells
(Figure 4d). By contrast, insulin treatment completely interfering with initial steps in NGF receptor signaling.
To determine whether formation of the pp90RSK–CBPblocked PEPCK induction by forskolin in H4 IIE cells,
but had no effect on forskolin-stimulated PEPCK mRNA complex was essential for NGF-dependent differentia-
tion of PC12 cells, we examined the morphology of wild-levels in the H4 RBD line. The loss of insulin-dependent
inhibition in H4 RBD cells did not appear to reflect a type and RBD-PC12 cells following growth factor induc-
tion. Wild-type PC12 cells appeared phase-bright anddeficiency in insulin receptor signaling, as revealed by
two-hybrid assays in which synergism between the extended neurites in response to NGF and forskolin.
By contrast, RBD-PC12 cells did not respond to NGFGAL4–RBD transgene and a pp90RSK VP16 expression
plasmid was induced by insulin (Figure 4b). treatment and became phase-bright and extended neu-
rites only in response to forskolin (Figure 6).
NGF has been shown to induce differentiation of PC12Formation of the pp90RSK–CBP Complex Is
cells in part by stimulating the transcription of specificRequired for NGF-Induced Differentiation
of PC12 Cells genes, including c-fos (Greenberg et al., 1985; Leonard
et al., 1987). To evaluate the importance of the pp90RSK–To determine whether other Ras-dependent growth fac-
tors in addition to insulin promote recruitment of pp90RSK CBP complex in mediating induction of NGF-responsive
genes, we examined the expression of the c-fos geneto CBP, we examined the effect of NGF on formation of
Multiple Pathways Converge on the Coactivator CBP
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Figure 6. pp90RSK–CBP Complex Formation
Is Critical for NGF-Induced Differentiation of
PC12 Cells
Light photomicrographs of wild-type and
RBD-PC12 cells, which express a GAL4–
CBP1680–1891 transgene, following48 hr of treat-
ment with NGF (50 ng/ml), forskolin (10 mM),
or DMSO vehicle (minus) in serum-free me-
dium. Bar represents 100 mm.
by Northern blot assay of total RNA from wild-type and RBD-PC12 cells rescued NGF-dependent stimulation of
the c-fos promoter, suggesting that pp90RSK activationRBD-PC12 cells. Following 1 hr of treatment with NGF,
c-fos mRNA was strongly induced in wild-type PC12 is required for NGF-responsive transcription.
Although RBD-PC12 cells were refractory to NGFcells (Figure 7a, compare lanes 1 and 3). By contrast,
RBD-PC12 cells were unable to stimulate c-fos mRNA induction, their responsiveness to cAMP agonists
was greater than in parental PC12 cells. Forskolin waslevels in response to NGF (Figure 7a, compare lanes 2
and 4). In contrast with wild-type PC12 cells, NGF was far more effective in stimulating tyrosine hydroxylase
mRNA accumulation, for example, in RBD-PC12 cellsunable to stimulate c-fos promoter activity in transient
transfection assays with RBD-PC12 cells (Figure 7b), compared with wild-type PC12 cells (Figure 7c). In tran-
sient transfection assays, forskolin stimulated a CRE-indicating that formation of the pp90RSK–CBP complex
is essential for transcriptional induction by NGF. In this CAT reporter 5–8 times more strongly in RBD-PC12
compared with wild-type PC12 cells (Figure 7d).regard, overexpression of a pp90RSK effector plasmid in
Figure 7. Overexpression of the RBD of CBP
in PC12 Cells Inhibits NGF- but Not cAMP-
Dependent Transcription
(a) Northern blot assay of total RNA from wild-
type (WT) or RBD-PC12 cells (RBD) following
treatment with NGF (50 ng/ml) or vehicle for
1 hr. Immobililzed RNAs were hybridized with
32P-labeled c-fos cDNA probe. Arrow points
to c-fos mRNA (FOS).
(b) Representative CAT assay of parental
(wild-type [WT]-PC12) and RBD-PC12 cells
following transfection with NGF-responsive
fos-CAT reporter plasmid FC 4 (Visvader et
al., 1988). Cells treated with NGF or vehicle
are indicated by a plusor minus, respectively.
Cotransfection with CMV-pp90RSK expression
vector (0, 5, or 20 mg) is indicated by cre-
scendo bar.
(c) Northern blot assay of total RNA from wild-
type (WT) and RBD-PC12 cells (RBD) treated
with forskolin (FSK) or DMSO vehicle (CON).
Immobilized RNAs were hybridized with
32P-labeled rat tyrosine hydroxylase cDNA
probe. Arrow points to tyrosine hydroxylase
(TH) mRNA.
(d) CAT assay of wild-type and RBD-PC12
cells using CRE-CAT reporter plasmid. Con-
trol and forskolin-treated cells are indicated
by striped and closed bars, respectively. CAT
activity is expressed as percent chloram-
phenicol converted to acetylated forms.
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Discussion CREB at Ser-133 in response to NGF. Remarkably, NGF-
induced phosphorylation of CREB at Ser-133 is not suffi-
cient, however, to induce transcription from a CRE re-A variety of growth factors, including epidermal growth
porter plasmid (Ginty et al., 1994). The inability of phos-factor, NGF, platelet-derived growth factor, and insulin,
pho-CREB per se to stimulate transcription in responsehave been shown to induce pp90RSK via a Ras-dependent
to NGF may reflect the inhibitory effects of the pp90RSK–mechanism (Chen et al., 1991; Erikson, 1991; Sturgill et
CBP complex on CREB activity.al., 1988; Wood et al., 1992). In quiescent cells, pp90RSK
The mechanism by which E1A and pp90RSK inhibit tran-appears to reside primarily in the cytoplasm, complexed
scription of cAMP-responsive genes upon binding toin part with MAPK (Hsiao et al., 1994). Following growth
CBP remains unclear. In this study, we found that bind-factor induction, pp90RSK is phosphorylated by MAPK
ing of pp90RSK to CBP did not preclude binding of phos-(Sturgill et al., 1988) and transported into the nucleus,
pho-CREB to CBP, indicating that pp90RSK may interferewhere it is thought to regulate transcription of mitogen-
instead with recruitment of a general transcription factorresponsive genes (Chen et al., 1992). Indeed, pp90RSK
to CBP. A number of basal transcription factors havehas been shown to phosphorylate a number of nuclear
been shown to interact with CBP (Kee et al., 1996; Kwokfactors in vitro, such as c-fos, Nur77, and serum re-
et al., 1994), and pp90RSK may inhibit the ability of onesponse factor (SRF) (Chen et al., 1992). Although phos-
or more of these to interact with CBP.phorylation of c-fos at a pp90RSK consensus phosphory-
lation site (Ser-362–Ser-364) is believed to be important
Experimental Proceduresfor transrepression of the c-fos promoter (Ofir et al.,
1990), the general importance of this kinase in signal- Plasmids
dependent transcription has been unclear. Cytomegalovirus-P300 vector was provided by D. Livingston (Dana
Farber Cancer Center). Dominant-negative (N17) and dominant-In this manuscript, we have demonstrated that pp90RSK
active (Val-61) Ras expression plasmids were a gift of M. Karinassociates with the signal-dependent coactivator CBP
(University of California, San Diego). Catalytically inactive RSK N9C9in response to growth factor signaling. Formation of the
contains Lys-112, Lys-464 to Arg-112, Arg-464 substitutions, which
pp90RSK–CBP complex is Ras dependent and occurs disrupt the ATP-binding site of each catalytic domain in pp90RSK
transiently in response to growth factor stimulation. (Fisher and Blenis, 1996).
pp90RSK binds to a region of CBP that is recognized by
Cell LinesE1A. As with E1A, binding of pp90RSK inhibits transcrip-
PC12 cells were maintained in DMEM supplemented with 10% fetaltional inductionof cAMP-responsivegenes by phospho-
calf serum (FCS). Jurkat T cells were grown in RPMI plus 10% FCS.
Ser-133 CREB (Arany et al., 1995; Lunblad et al., 1995). H4IIE cells (provided by M. Chojkier, University of California, San
The pp90RSK–CBP complex is kinetically stable, per- Diego) were grown in DMEM supplemented with 1% nonessential
amino acids plus 10% FCS and 10% calf serum. Expression ofsisting for up to 6 hr following growth factor stimulation.
dominant-negative Ras protein in PC12 GSRasDN1 cells (gift of S.When complexed to CBP, pp90RSK appears to remain
Halegoua, SUNY, Stonybrook) was induced by overnight treatmentcatalytically active. CBP contains a single pp90RSK con- with 1027 M dexamethasone. To isolate stably transfected H4IIE (H4
sensus phosphorylation site at Ser-1772 (RRLS), which RBD) and PC12 (RBD-PC12) lines, cells were cotransfected with
is efficiently phosphorylated in immune complex kinase GAL4 or GAL4–RBD expression vectors (20 mg) plus neomycin resis-
assays (M. R. M. and T. N., unpublished data). However tance plasmid (1 mg). Individual cell clones were identified following
antibiotic selection with G418 as previously described (Montminymutagenesis of the pp90RSK phospho-acceptor site does
et al., 1986).not appear to alter CBP activity (Kwok et al., 1994), and
our results indicate that the catalytic activity of pp90RSK Transient Transfection Assays
is not required for transcriptional repression of cAMP- Transfection assays were performed on at least three independent
responsive genes. The ability of catalytically inactive occasions. CAT activity was normalized to b-galactosidase activity
derived from cotransfected RSV-bGal expression plasmid.mutant pp90RSK to associate with CBP and inhibit tran-
scription of cAMP-responsive genes, although unex-
Western Blot, Immune Complex Kinase Assays,pected, is also consistent with the stability of the and Immunoprecipitations
pp90RSK–CBP complex in growth factor–stimulated cells. Nuclear extracts were prepared as described by Schreiber et al.
In addition to mediating transcriptional repression of (1989). Western blot assays for total and phospho-Ser-133 CREB
have been describedpreviously (Brindle et al., 1995). Immunoprecip-cAMP-responsive genes, the pp90RSK–CBP complex
itates of CBP were prepared from nuclear extracts using CBP antise-also appears to beessential for induction of Ras-respon-
rum 5614, which was raised against the CREB-binding domain ofsive genes. Induction of the c-fos gene by NGF, for
CBP (amino acids 455–679). Complexes were washed with co-IP
example, has been shown to rely primarily on a serum- buffer, which contained 0.1% Tween 20, 50 mM HEPES (pH 7.4),
responsive element (SRE), which recognizes SRF and 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 1 mM DTT, 10% glycerol,
1 mM NaF. Immune complex kinase assays were performed on CBPElk-1/SAP-1 (Hill et al.,1993; Hipskind et al., 1991). Cellu-
immunoprecipitates with purified peptide substrates using an S6lar microinjection experiments with anti-CBP antiserum
kinase assay kit supplied by Upstate Biotechnology. Western blothave revealed that CBP is required for SRE-dependent
and immunoprecipitation assays of pp90RSK were performed usingtranscription (Arias et al., 1994). In addition, our results polyclonal antiserum raised against amino acids 508–525 of rat
suggest that formation of thepp90RSK–CBP complex may pp90RSK (Santa Cruz).
promote a productive interaction between CBP and pro-
In-Gel Kinase Assays, Phosphoamino Acid Analysis,teins such as SRF or Elk-1, which bind the SRE.
and GST Pull-Down AssaysGinty et al. (1994) have observed that CREB activity
In-gel kinase assays of CBP immunoprecipitates were performed
is also required for c-fos induction by NGF. A 100 kDa as described previously (Kameshita and Fujisawa, 1989). Phospho-
Ras-dependent Ser/Thrkinase with biochemical proper- amino acid analysis was performed as previously reported (Yama-
moto et al., 1988). 32P-labeled recombinant phospho-Ser-133 CREBties similar to pp90RSK has been shown to phosphorylate
Multiple Pathways Converge on the Coactivator CBP
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was prepared and GST pull-down assays were performed as de- R. (1993). Functional analysis of a growth factor–responsive tran-
scription factor complex. Cell 73, 395–406.scribed previously (Parker et al., 1996).
Hipskind, R., Rao, V., Mueller, C., Reddy, E., andNordheim, A. (1991).
Northern Blot Assays Ets-related protein Elk-1 is homologous to the c-fos regulatory fac-
Northern blot analysis was performed as previously described (Leo- tor p62TCF. Nature 354, 531–534.
nard et al., 1993) using random primer–labeled a-tubulin, c-fos, and Hsiao, K., Chou, S., Shih, S., and Ferrell, J. (1994). Evidence that
PEPCK cDNAs (gift of R. Hanson, Case Western Reserve University). inactive p42 mitogen-activated protein kinase and inactive Rsk exist
as a heterodimer in vivo. Proc. Natl. Acad. Sci. USA 91, 5480–5484.
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